Intra-Cellular Therapies

-$0.86 (-2.44%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITCI and other ETFs, options, and stocks.

About ITCI

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS.

CEO

Sharon Mates

Employees

383

Headquarters

New York, New York

Founded

2013

ITCI Key Statistics

Market Cap

3.28B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

452.69K

High Today

$35.33

Low Today

$34.07

Open Price

$35.00

Volume

278.68K

52 Week High

$44.80

52 Week Low

$17.26

Analyst Ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

ITCI Earnings

-$1.00

-$0.67

-$0.33

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 9, Pre-Market